![Timothy Edwards](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 74 583 $ am 30.06.2026
Timothy Peter Warren Edwards is Independent Non-Executive Chairman at Schroders Capital Global Innovation Trust Plc since 2021.
He is Non-Executive Chairman at STORM Therapeutics Ltd. since 2015.
He serves as Chairman at the Institute For Research In Schools since 2018.
He holds the position of Chairman at Senisca Ltd., Endlyz Therapeutics, Inc., and Endlyz UK Ltd. He is Governor at Magdalen College School.
Former roles include President & Chief Executive Officer at Cellzome, Inc. Chairman at The Bioindustry Association from 2007 to 2014.
Chairman at Atopix Therapeutics Ltd. from 2012 to 2016.
Executive Chairman at Karus Therapeutics Ltd. Chairman at AstronauTx Ltd. Director at Innovate UK.
Director-Corporate Finance at NatWest Markets.
Non-Executive Director at Cell Therapy Catapult Ltd. from 2013 to 2015.
Director at Ervaxx Ltd. from 2017 to 2020.
Independent Non-Executive Director at Record Plc from 2018 to 2024.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RECORD PLC 0.03% | 31.03.2025 | 60’000 ( 0.03% ) | 37 747 $ | 30.06.2026 |
| 31.12.2025 | 165’199 ( 0.03% ) | 36 836 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHRODERS CAPITAL GLOBAL INNOVATION TRUST PLC - INOV | Vorsitzender | 04.06.2021 |
Endlyz UK Ltd. | Vorsitzender | - |
Endlyz Therapeutics, Inc.
 Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology industry | Vorsitzender | - |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Vorsitzender | 01.06.2015 |
Magdalen College School
 Magdalen College School Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Institute For Research In Schools | Vorsitzender | 01.02.2018 |
Senisca Ltd.
 Senisca Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
Astronautx Ltd.
 Astronautx Ltd. Miscellaneous Commercial ServicesCommercial Services Develops small molecule therapeutics for neurodegenerative diseases | Vorsitzender | 07.01.2026 |
| RECORD PLC | Direktor/Vorstandsmitglied | 25.06.2024 |
| ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 17 |
|---|---|
Record Plc
 Record Plc Financial ConglomeratesFinance Provides currency investment and hedging services for institutional clients | Finance |
Innovate UK
 Innovate UK Miscellaneous Commercial ServicesCommercial Services Promotes, supports and invests in technology research, development and commercialisation | Commercial Services |
NatWest Markets
 NatWest Markets Major BanksFinance Commercial banking; US & foreign | Finance |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Provides therapies for treatment of cancer and inflammatory diseases | Health Technology |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Cellzome, Inc.
 Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-inflammation therapy | Health Technology |
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel class of medicines to treat atopic dermatitis and severe asthma | Health Technology |
Schroders Capital Global Innovation Trust Plc
 Schroders Capital Global Innovation Trust Plc Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Engages in development of cell and gene therapy | Health Technology |
Magdalen College School
Magdalen College School Other Consumer ServicesConsumer Services College/University | Consumer Services |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Health Technology |
Institute For Research In Schools | |
Astronautx Ltd.
Astronautx Ltd. Miscellaneous Commercial ServicesCommercial Services Develops small molecule therapeutics for neurodegenerative diseases | Commercial Services |
Senisca Ltd.
Senisca Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company | Commercial Services |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology industry | Health Technology |
Enara Bio Ltd.
 Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies | Health Technology |
Endlyz UK Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
